Redmile Group

Funding rounds backed by Redmile Group.

Export CSV
Funding disclosed in full
$66M
Median round
$66M
Rounds in calculation
1
1 round
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Abcuro

Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases

$66MSeries DBiotechUnited States
17 participantsabrdnBain Capital Life SciencesEurofarma VenturesForesite CapitalKaitai CapitalMass General Brigham VenturesNancy ChangNew Enterprise Associates (NEA)New Leaf Venture PartnersPontifaxRA Capital ManagementRedmile GroupRock Springs CapitalSamsara BioCapitalSanofi VenturesShang BaySoleus Capital